Authors

Latest:

Differentiated Thyroid Cancer: Unmet Needs and Future Directions

Experts highlight remaining unmet needs in the management of radioiodine-refractory differentiated thyroid cancer and share their hopes for the future.

Marcia Brose, MD, PhD, Perelman School of Medicine

Marcia Brose, MD, PhD, University of Pennsylvania

Latest:

Overview on Differentiated Thyroid Cancer (DTC)

Opening discussion on the advent of differentiated thyroid cancer (DTC) and management, moderator Lori J. Wirth, MD, provides and overview of prevalence, subtypes, and prognosis.

Marcia Frellick

Latest:

Collaboration in Groups Improves Care, Averts Pay Cuts

Urologists who are members of LUGPA are doing the right thing by being part of large group practices.

Marcia S. Brose, MD, PhD

Latest:

Exploring Real-World Evidence Presented at ATA 2023

Medical professionals discuss the recently published real-world evidence presented at the American Thyroid Association 2023 Conference.

Marcia S. Brose, MD, PhD Abramson Cancer Center

Marcia S. Brose, MD, PhD, University of Pennsylvania

Latest:

Diagnosing DTC: Clinical Workup and Molecular Testing

Shared insight on best practices in diagnosing patients with differentiated thyroid cancer with a focus on histologic and molecular subtypes.

Marcia S. Brose, MD, PhD, UPenn

Marco Ruiz, MD

Latest:

Dr. Ruiz on the HIV-Oncology Clinic Program

Marco Ruiz, MD, associate physician, Moffitt Cancer Center, discusses HIV-Oncology Clinic at the Association of Community Cancer Centers (ACCC) National Oncology Conference.

Marcovalerio Melis, MD

Latest:

Dr. Melis on Avoiding Surgery for Patients With Rectal Cancer

Marcovalerio Melis, MD, associate professor, Department of Surgery, NYU Langone Medical Center, discusses a study examining if surgery can be avoided in patients with advanced rectal cancer by using diffusion-weighted magnetic resonance imaging to predict pathologic response.

Marcus Albertsmeier, MD

Latest:

Dr. Albertsmeier on Radiation Therapy for Soft Tissue Sarcoma

Marcus Albertsmeier, MD, surgeon at Ludwig Maximilian University of Munich, discusses the effect of radiation therapy on local recurrence and overall survival for patients with soft tissue sarcoma.

Marcus Bosenberg, MD, PhD

Latest:

Dr. Marcus Bosenberg on Mouse and Other Models for Immunotherapy

Marcus Bosenberg, MD, PhD, associate professor of dermatology and pathology, Yale University, discusses mouse models for testing immunotherapies.

Marcus Neubauer, MD

Latest:

Can New Oncology Payment Programs Help Stabilize Medicare?

Studies have raised doubts about the value Medicare and other payers are getting for the care they pay for, including in oncology. This has intensified the demand for new value-based care models such as the Merit-based Incentive Payment System and the Oncology Care Model.

Marcus Noel, MD

Latest:

Dr. Noel on the Impact of SM-88 in Pancreatic Cancer

Marcus Noel, MD, discusses the data of SM-88 and how it will impact the treatment of patients with metastatic pancreatic cancer.

Margaret A. Tempero, MD

Latest:

Dr. Tempero on Role of Molecular Profiling in Pancreatic Cancer

Margaret A. Tempero, MD, director, University of California, San Francisco (UCSF) Pancreas Center, professor of medicine, Division of Hematology and Oncology, Rombauer Family Distinguished Professor in Pancreas Cancer Clinical and Translational Science, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the role of molecular profiling in pancreatic cancer.

Mari Pestil Zimmerman

Latest:

Targeted Therapies Yield Most Promising Results: A New Era in Melanoma Treatment Has Begun

Melanoma is one of the most frequent cancers; more than 2 million Americans are treated for skin cancer annually.

Maria Chaudhry, MBBS

Latest:

Dr. Chaudhry on Novel Treatment Regimens in Relapsed/Refractory Multiple Myeloma

Maria Chaudhry, MBBS, a hematologist at The Ohio State University Comprehensive Cancer Center—James, discusses novel treatment regimens in relapsed/refractory multiple myeloma.

Maria D. Cappellini, MD

Latest:

Dr. Cappellini on Splenectomy in Gaucher Disease Patients

Dr. Maria Cappellini, Maggiore Hospital, Milan, Italy, on Splenectomy in Gaucher Disease Patients.

Maria De Santis, MD

Latest:

Dr. De Santis on the Future Treatment Landscape for Bladder Cancer

Maria De Santis, MD, associate clinical professor at the University of Warwick, discusses the future treatment landscape for patients with bladder cancer.

Maria Diaz-Meco, PhD

Latest:

Novel Protein Research May Help Unravel Obesity-Cancer Link

Researchers of Sanford Burnham Prebys Medical Discovery Institute indicates that p62 may represent a link connecting obesity, inflammation, and progression of certain cancers.